Improving care for patients with severe infections and substance use issues.
INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02
This study is looking at how to better help patients in the hospital who are facing serious infections and struggles with substance use, by providing them with a complete care plan that meets both their medical and emotional needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10720986 on NIH RePORTER |
What this research studies
This research focuses on integrating care for hospitalized patients who are dealing with severe infectious diseases and substance use disorders. The approach involves a comprehensive treatment plan that addresses both the medical and psychological needs of these patients. By utilizing a collaborative care model, the research aims to improve patient outcomes through coordinated interventions and support. Patients will receive tailored treatment strategies that consider their unique circumstances and health challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients who are experiencing severe infectious diseases alongside substance use disorders.
Not a fit: Patients who do not have substance use disorders or severe infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better health outcomes for patients suffering from both severe infections and substance use disorders.
How similar studies have performed: Previous research has shown that integrated care approaches can be effective in managing co-occurring health issues, suggesting potential success for this novel approach.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.